🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Europe's STOXX 600 slips, but marks seventh week of gains

Published 02/12/2022, 08:33
Updated 02/12/2022, 17:26
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, November 25, 2022. REUTERS/Staff/Files
STOXX
-

By Susan Mathew and Devik Jain

(Reuters) - European shares fell back on Friday after two days of strong gains that helped the STOXX 600 index notch up its seventh straight week of rises amid signs of China re-opening its economy and easing worries about interest-rate hikes.

The pan-European index closed 0.2% lower after rallying 1.5% in the last two sessions. The index gained 0.6% over the week, and registered its longest weekly winning streak since April 2021.

Energy and technology (SX8P) stocks were among the biggest drags on the broader index, offsetting gains in real estate and retailers.

"There appears to be some profit-taking after sessions characterised mostly by risk-on appetite. Optimism towards the economic reopening in China has helped drive gains," Victoria Scholar, head of investment at Interactive Investor, said.

Chinese officials this week softened their stance on strict COVID curbs that have hit global growth amid protests in the country. [MKTS/GLOB]

Rate-sensitive technology stocks also took a hit as euro zone government bond yields rose in line with a move in U.S. Treasury yields after data showed U.S. employers hired more workers than expected in November and increased wages despite mounting worries of a recession.

"Strong job creation and a big increase in wages underscore the Federal Reserve's argument that a lot more work needs to be done to get inflation under control," James Knightley, chief international economist at ING, said in a note.

"It has certainly jolted the market. But with recessionary fears lingering, market participants will remain sceptical over how long the strong performance can last."

Data this week from Europe showing cooling inflation and falling German retail sales and exports have also made the case for the European Central Bank to opt for a smaller hike.

However, ECB Vice-President Luis de Guindos said on Friday the central bank needs to focus on bringing inflation down to its 2% mid-term goal and therefore keep raising interest rates despite a recent deceleration in the pace of price rises.

Among individual stocks, French drugmaker Sanofi (EPA:SASY) fell 1.9% after saying that if it bid for biotech company Horizon Therapeutics Plc, it would do so in cash.

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, November 25, 2022. REUTERS/Staff/Files

Horizon, with a market capitalization of about $18 billion, is also in talks with Amgen Inc (NASDAQ:AMGN) and Johnson & Johnson (NYSE:JNJ) unit Janssen Global Services over potential takeover offers.

Credit Suisse (SIX:CSGN) jumped 9.3% after 12 straight days of losses that sent the stock to a record low. The Swiss lender is looking to speed up cost cutting as the revenue outlook worsens.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.